Equities Research Analysts’ Updated EPS Estimates for August 27th (AAPL, AFRM, AMRC, BAND, BMRN, BNTX, BNZL, CDIO, CLSD, COST)

Equities Research Analysts’ updated eps estimates for Tuesday, August 27th:

Apple (NASDAQ:AAPL) had its outperform rating reissued by analysts at Evercore ISI. They currently have a $250.00 price target on the stock.

Apple (NASDAQ:AAPL) had its buy rating reaffirmed by analysts at Bank of America Co.. Bank of America Co. currently has a $256.00 price target on the stock.

Apple (NASDAQ:AAPL) had its buy rating reaffirmed by analysts at Melius Research. The firm currently has a $265.00 target price on the stock.

Apple (NASDAQ:AAPL) had its neutral rating reissued by analysts at Piper Sandler. Piper Sandler currently has a $225.00 price target on the stock.

Apple (NASDAQ:AAPL) had its overweight rating reaffirmed by analysts at Morgan Stanley. The firm currently has a $273.00 price target on the stock.

Apple (NASDAQ:AAPL) had its buy rating reissued by analysts at Citigroup Inc.. The firm currently has a $255.00 target price on the stock.

Affirm (NASDAQ:AFRM) had its outperform rating reissued by analysts at Mizuho. The firm currently has a $65.00 price target on the stock.

Ameresco (NYSE:AMRC) had its outperform rating reaffirmed by analysts at Robert W. Baird. The firm currently has a $32.00 price target on the stock.

Bandwidth (NASDAQ:BAND) had its market outperform rating reiterated by analysts at JMP Securities. The firm currently has a $36.00 price target on the stock.

BioMarin Pharmaceutical (NASDAQ:BMRN) had its overweight rating reissued by analysts at Piper Sandler. They currently have a $107.00 target price on the stock.

BioNTech (NASDAQ:BNTX) had its buy rating reissued by analysts at HC Wainwright. They currently have a $113.00 price target on the stock.

Bunzl (LON:BNZL) had its buy rating reiterated by analysts at Shore Capital.

Cardio Diagnostics (NASDAQ:CDIO) had its speculative buy rating reaffirmed by analysts at Benchmark Co.. The firm currently has a $2.00 price target on the stock.

Clearside Biomedical (NASDAQ:CLSD) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $5.00 price target on the stock.

Costco Wholesale (NASDAQ:COST) had its outperform rating reaffirmed by analysts at Telsey Advisory Group. The firm currently has a $925.00 target price on the stock.

Campbell Soup (NYSE:CPB) had its sector perform rating reiterated by analysts at Royal Bank of Canada. They currently have a $47.00 price target on the stock.

Campbell Soup (NYSE:CPB) had its hold rating reiterated by analysts at Stifel Nicolaus. Stifel Nicolaus currently has a $45.00 target price on the stock.

Cyclo Therapeutics (NASDAQ:CYTH) had its hold rating reaffirmed by analysts at Maxim Group.

Krispy Kreme (NASDAQ:DNUT) had its in-line rating reissued by analysts at Evercore ISI. The firm currently has a $13.00 price target on the stock.

ECO Animal Health Group (LON:EAH) had its buy rating reaffirmed by analysts at Shore Capital.

Elastic (NYSE:ESTC) had its buy rating reaffirmed by analysts at Rosenblatt Securities. They currently have a $136.00 price target on the stock.

Evolent Health (NYSE:EVH) had its buy rating reiterated by analysts at Truist Financial Co.. The firm currently has a $33.00 target price on the stock.

Five9 (NASDAQ:FIVN) had its buy rating reiterated by analysts at Truist Financial Co.. Truist Financial Co. currently has a $65.00 price target on the stock.

Glacier Bancorp (NASDAQ:GBCI) had its neutral rating reiterated by analysts at Piper Sandler. Piper Sandler currently has a $38.00 target price on the stock.

Genmab A/S (NASDAQ:GMAB) had its buy rating reissued by analysts at HC Wainwright. They currently have a $50.00 target price on the stock.

HEICO (NYSE:HEI) had its buy rating reaffirmed by analysts at Benchmark Co.. They currently have a $245.00 price target on the stock.

IAC (NASDAQ:IAC) had its buy rating reiterated by analysts at Benchmark Co.. They currently have a $110.00 target price on the stock.

Invivyd (NASDAQ:IVVD) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $15.00 target price on the stock.

Leslie’s (NASDAQ:LESL) had its market perform rating reiterated by analysts at Telsey Advisory Group. The firm currently has a $4.00 price target on the stock.

Eli Lilly and Company (NYSE:LLY) had its overweight rating reiterated by analysts at Morgan Stanley. They currently have a $1,106.00 price target on the stock.

OKYO Pharma (NASDAQ:OKYO) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $7.00 target price on the stock.

Roper Technologies (NYSE:ROP) had its buy rating reiterated by analysts at Truist Financial Co.. The firm currently has a $660.00 price target on the stock.

SolarEdge Technologies (NASDAQ:SEDG) had its hold rating reissued by analysts at Truist Financial Co.. The firm currently has a $20.00 target price on the stock.

Skye Bioscience (NASDAQ:SKYE) had its overweight rating reiterated by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $14.00 price target on the stock.

Skye Bioscience (NASDAQ:SKYE) had its overweight rating reissued by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $14.00 target price on the stock.

Shattuck Labs (NASDAQ:STTK) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $16.00 target price on the stock.

Trip.com Group (NASDAQ:TCOM) had its buy rating reiterated by analysts at Benchmark Co.. Benchmark Co. currently has a $72.00 target price on the stock.

Zoetis (NYSE:ZTS) had its buy rating reaffirmed by analysts at Stifel Nicolaus. The firm currently has a $200.00 target price on the stock.